Table 2.
EVA1B staining expression associations with clinicopathologic and survival characteristics in CRC patients.
| Variable | No. | Negative | Positive | p-value |
|---|---|---|---|---|
| Clinicopathologic characteristics | ||||
| Age (years) | 0.922 | |||
| <60 | 60 | 24 | 36 | |
| ≥60 | 71 | 29 | 42 | |
| Gender | 0.091 | |||
| Male | 71 | 24 | 47 | |
| Female | 60 | 29 | 31 | |
| Location | 0.596 | |||
| Colon | 63 | 24 | 39 | |
| Rectum | 68 | 29 | 39 | |
| Differentiation | 0.884 | |||
| Poor | 18 | 7 | 11 | |
| Well | 113 | 46 | 67 | |
| pT stage | 0.141 | |||
| T1–T3 | 92 | 41 | 51 | |
| T4 | 39 | 12 | 27 | |
| pN stage | <0.001 | |||
| N0 | 60 | 38 | 22 | |
| N1–N2 | 71 | 15 | 56 | |
| pM stage | 0.005 | |||
| M0 | 109 | 50 | 59 | |
| M1 | 22 | 3 | 19 | |
| AJCC stage | 0.001 | |||
| I | 17 | 12 | 5 | |
| II | 36 | 25 | 11 | |
| III | 56 | 13 | 43 | |
| IV | 22 | 3 | 19 | |
| CEA | 0.003 | |||
| ≤5.0 (negative) | 79 | 40 | 39 | |
| >5.0 (positive) | 52 | 13 | 39 | |
| CA199 | 0.002 | |||
| ≤37.0 (negative) | 114 | 52 | 62 | |
| >37.0 (positive) | 17 | 1 | 16 | |
| Survival characteristics | ||||
| 1-year survival | 131 | 53 (100%) | 78 (100%) | NS |
| 2-year survival | 125 | 52 (98.1%) | 73 (93.6%) | NS |
| 3-year survival | 108 | 50 (94.3%) | 58 (74.4%) | 0.048 |
| 4-year survival | 94 | 44 (83.0%) | 50 (64.1%) | 0.018 |
| 5-year survival | 87 | 44 (83.0%) | 43 (55.1%) | <0.001 |
| 6-year survival | 77 | 42 (79.3%) | 35 (44.9%) | <0.001 |
| 7-year survival | 75 | 42 (79.3%) | 33 (42.3%) | <0.001 |
NS, no significance.